Abbott is an American multinational medical devices and health care company that is recognized for M&A, Product Launches, Research and Development and Social in the 2022 Hospital Management Network Excellence Awards.
During the COVID 19 pandemic, Abbott focused on developing and launching test kits, including its Panbio COVID-19 antigen self-test in India. The minimally invasive nasal swab received the EU’s CE Mark for over-the-counter use in adults and children. Abbot has also shown social responsibility in partnering with companies like Cardinal Health and Quidel to improve access to over-the-counter rapid tests.
The company has also been active in the realm of monitoring devices, launching an insertable cardiac monitor for abnormal heart rhythms called Jot Dx, a monitoring system for earlier-stage heart failure called CardioMEMS and an app for diabetes management.
Other cardiovascular solutions the company has been developing include a cardiac mapping platform, a leadless pacemaker and invasive devices for transcatheter aortic valve replacement.
Abbott discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products.
The company has also been active in the realm of monitoring devices
The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices.
The company also offers minerals and nutrition products and dietary supplements. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world.
The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific, and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.